INOVIQ

INOVIQ Ltd (ASX:IIQ) (INOVIQ) is developing and commercialising an innovative portfolio of diagnostic and exosome-based products to improve the diagnosis and treatment of cancer and other diseases. The Company has commercialised the hTERT test used as an adjunct to urine cytology testing for bladder cancer and the EXO-NET pan-exosome capture tool for research purposes. Their cancer diagnostic…More pipeline includes blood tests in development for earlier detection and monitoring of ovarian, breast, prostate, and other cancers.